
High levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 might be a biomarker of activity in pediatric patients with MOG-AD
Author(s) -
Anna Zhou,
Weihua Zhang,
Changhong Ren,
Ji Zhou,
Huoy-Rou Chang,
Xiaotun Ren
Publication year - 2022
Publication title -
frontiers in pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.96
H-Index - 36
ISSN - 2296-2360
DOI - 10.3389/fped.2022.908527
Subject(s) - microglia , cerebrospinal fluid , medicine , multiple sclerosis , biomarker , trem2 , myelin oligodendrocyte glycoprotein , neurodegeneration , immunology , ectodomain , neuroinflammation , receptor , disease , pathology , inflammation , biology , experimental autoimmune encephalomyelitis , biochemistry